In their research activities
or in their quality control obligations,
pharmaceutical companies are major producers and consumers of morphologicalimages both in brightfield and in fluorescence. Digital
pathology allows these companies to perform high-throughput screening on molecules and to work on a
series of slides with efficiency and consistency. Uses can be in Drug Discovery or in toxicopathology.
TRIBVN delivers its expertise by providing them with high-speed scanning solutions with an integrated environment built around the
Moreover its ability to design and deploy screening automation equipements enables TRIBVN to answer to specific
requests from Biotech which have innovative diagnostic solutions.